A transformative preclinical model for advancing precision immunotherapy in mismatch repair-deficient endometrial cancer
Active Project Grant Awarded Last action
- Award ID
- HT9425261E469
- Recipient
-
University Of Oklahoma UEI GY8NMUZQXVS7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $557,612
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 0% complete
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded the University of Oklahoma Health Sciences Center $557,612 on November 1, 2026, through the Military Medical Research and Development program (CFDA 12.420) to develop a transformative preclinical model for advancing precision immunotherapy in mismatch repair-deficient endometrial cancer. Performance occurs at Oklahoma City, Oklahoma, with work concluding October 31, 2028.
Quick answers
Who received award HT9425261E469?
HT9425261E469 was awarded to University Of Oklahoma by Defense Health Agency (Department of Defense) on November 1, 2026.
How much is award HT9425261E469 worth?
$557,612 has been obligated on HT9425261E469.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award